Generic Name: Clonazepam
Klonopin, a brand name for the benzodiazepine clonazepam, is used in the treatment of seizure disorders and panic disorder. Off label it is used for restless leg syndrome, neuralgia, multifocal tic disorder, parkinsonian dysarthria, bipolar disorder and as an adjunct in treatment of schizophrenia.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Anxiety | 178 |
|
|
|
|
|
50 |
| Other | 41 |
|
|
|
11 | ||
| Stiffness/Spasticity | 30 |
|
|
|
|
7 | |
| Treat my mood condition(s) | 29 |
|
|
|
7 | ||
| Insomnia | 29 |
|
|
|
9 | ||
| difficulty getting to sleep at night | 27 |
|
|
|
|
5 |
See all 393 patients currently taking Klonopin
Mouse over the table for more information
Top 10 dosages based on patients currently taking Klonopin. See all 31 dosages ►
| 0.25mg as needed | 0.5 as needed | 0.5 mg as needed | 0.5mg as needed | 10mg as needed | 1.5mg as needed | 1 mg all the time (24/7) | 1mg as needed | 2 0.125mg as needed | 2 0.5mg as needed | 2 mg all the time (24/7) | 2mg as needed | 6 0.5mg as needed | 0.05 mg daily | 0.125 mg daily | 0.25 mg daily | 0.5 mg daily | 0.375 mg daily | 0.5 mg daily | 1 mg daily | 1.25 mg daily | 1.5 mg daily | 2 mg daily | 3 mg daily | 3.5 mg daily | 4 mg daily | 6 mg daily | 10 mg daily | 15 mg daily | 20 mg daily | 200 mg daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
6
|
1
|
2
|
40
|
2
|
1
|
3
|
12
|
1
|
2
|
2
|
2
|
1
|
1
|
10
|
11
|
1
|
4
|
66
|
98
|
1
|
30
|
54
|
23
|
1
|
12
|
6
|
1
|
2
|
1
|
1
|
||
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Doctor's advice
|
14 | 27% |
|
|
Other
|
14 | 27% |
|
|
Did not seem to work
|
13 | 25% |
|
|
Side effects too severe
|
12 | 23% |
|
|
Course of treatment ended
|
8 | 15% |
|
|
Expense
|
2 | 4% |
|
|
Personal research
|
1 | 2% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 22, 2009.